An innovative project of Mount Sinai Medical Center in New York City, HepCure is improving provider knowledge & patient engagement for chronic disease management in persons infected with the Hepatitis C Virus (HCV). The toolkit is designed to address barriers for the effective care and treatment of HCV by providing web-based and smartphone enabled resources, navigation, consultation, and support for both patients and providers. The HepCure toolkit draws upon the experience of expert providers within the Mount Sinai Network, with support and development by Sinai AppLab, Mount Sinai Medical Center. HepCure was developed by the Mount Sinai Division of Liver Diseases, Division of General Internal Medicine, and the Informatics for Research, Outcomes, and Quality initiative in the Division of Gastroenterology.
HepCure is a secure, cloud-based provider portal meant to virtually navigate providers through hepatitis C virus (HCV) care. The HepCure dashboard integrates tools to more effectively manage HCV infected patients. A flexible, scalable platform, the HepCure Dashboard provides a seamless flow of information within a digital healthcare infrastructure. HepCure enables easy access to HCV resources and best-practices for optimal management of HCV patients with the opportunity to engage patients on treatment, while improving overall health outcomes. The platform serves as an organizational tool, with built-in workflow efficiencies that optimize treatment decisions, reduce redundancies, as well as promote provider training and development.
Through the use of the dashboard and patient app, providers can:
We at HepCure are always looking for ways to improve. That’s why we’re constantly working on new features and meeting new challenges! Here are just a few of the features we plan to explore:
The patient app is a free resource for patients with hepatitis C, which allows them to track medication adherence, symptoms, and gain access to resources. It is available to download for free on iOS (App Store) and Android (Google Play) operating systems. While the app can be used by patients independently from the dashboard, it can also be linked with the provider dashboard. Providers can push lab data to patients and track treatment adherence and symptom data input by patients in real time.
The HepCure Tele-Education Webinar Series features many diverse and salient topics in hepatitis C. Each week, the webinar series showcases different speakers who are prominent members of the hepatitis C community. Our webinars are attended by a wide audience, and include providers, patient navigators, and other health workers from around the globe. Our collaboration with the New York State Clinical Education Initiative (CEI) and Empire Liver Foundation (ELF) allows us to provide continuing education credits (CME/CNE) through attendance to our webinars on the first and last Tuesday of every month.
All webinars are held on Tuesdays from 4:30 - 5:30pm EST
Please join us on Tuesday, September 25th for a presentation by Dr. Ira Jacobson, Director of Hepatology of NYU Langone Medical Center. Dr. Jacobson will present:
“Stump the Expert”
About Dr. Jacobson:
Please join us on Tuesday, September 11th at 4:30 PM EST for a presentation by Dr. Christian B. Ramers, MPH, AAHIVS. Dr. Ramers will present on:
“Hepatitis C and Drug Use: Addressing Screening, Treatment, and Stigma.”
1. Review the epidemiology of HCV among people who use drugs (PWUD).
2. Describe HCV transmission among PWUD and the role of drug use in HCV transmission.
3. Discuss the importance of treating PWUD and available treatment regimens.
o Dr. Ramers is the Assistant Medical Director for Research and Special Populations at the Family Health Centers of San Diego, a large Federally Qualified Health Center (FQHC) system serving nearly 200,000 medically underserved individuals throughout San Diego County. He serves as a primary care physician and consultant for patients living with HIV, HBV, HCV, Tuberculosis, and for those who are homeless or in residential drug and alcohol rehabilitation programs. He helps lead a buprenorphine and naloxone-based Medication Assisted Treatment (MAT) program, as well as several grant-funded educational initiatives designed to adapt HIV and HCV care in the primary care setting using telehealth mentoring platforms.
– Scientific Advisory Board: Gilead, Abbvie
– Speaker’s Bureau: Gilead, Merck, AbbVie, Janssen, Clinical Care Options
– Research Grants/Consulting: Gilead, HRSA/SPNS, NIH, NCI, SAMHSA, CA Dept Public Health, Project ECHO, HealthHIV, Clinton Health Access Initiative (CHAI)
Continuing Medical Education
The University of Rochester School of Medicine and Dentistry is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
The University of Rochester School of Medicine and Dentistry designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Nursing Education
The University of Rochester Center for Nursing Professional Development is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
1.0 Nursing Contact Hours will be provided.
Continuing Pharmacy Education
The University at Buffalo School of Pharmacy and Pharmaceutical Sciences is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. “Hepatitis C and Drug Use: Addressing Screening, Treatment, and Stigma”, a knowledge-based live activity has been assigned ACPE #0044-9999-18-031-L01-P and will award 1 contact hour of continuing pharmacy education credit. No partial credit will be awarded.
These learning modules are intended for clinicians of all backgrounds who may encounter or treat patients with hepatitis C and would like to establish core competencies in screening & diagnosis, evaluation and management of the disease. Content includes screening and linkage to care, initial evaluation, diagnosis and recognition of clinical manifestations. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
These learning modules are intended for clinicians who have experience treating patients with hepatitis C and would like to further their knowledge. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment
THe Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C) is a free interactive online tool that enables you to provide a thorough assessment of a patient’s psychosocial readiness to begin Hepatitis C treatment, and make a treatment plan to improve treatment readiness.
This free online tool can be used by any type of professional involved in preparing a patient for Hepatitis C Treatment including medical providers, nurses, mental health, substance use, social work, pharmacy, case management, treatment adherence and health education specialists.